Friday, July 31, 2026

Christopher Nolan’s Odyssey: A Record-Breaking Global Box Office Hit!

Christopher Nolan's film *Odyssey* tops box office charts globally, earning $264.06 million and receiving critical acclaim.

THE BIG LIE: North Korea Unveils Hospital That Proves Its Healthcare Was A 70-Year-Old Death Trap

Kim Jong Un inaugurated the Gangdong County Hospital, emphasizing it as a model for local healthcare modernization in North Korea.

Federal Register Watch: South Korea Scrambles to Stop a 25% Auto Tariff Before March 9

South Korea's government is working to delay U.S. tariffs on automobiles, aiming for a grace period while negotiating legislative actions.

Tag: Cartistem

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

CARTISTEM vs. Traditional Treatments: What Makes Medipost’s Stem Cell Therapy a Game-Changer?

Medipost to commercialize CARTISTEM in Japan using domestically produced media, enhancing supply chain stability and competitiveness.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.